| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Basta-Kaim, K Fijał, B Budziszewska, M Regulska, M Leśkiewicz, M Kubera, K Gołembiowska, W Lasoń, K Wędzon. Prenatal lipopolysaccharide treatment enhances MK-801-induced psychotomimetic effects in rats. Pharmacology, biochemistry, and behavior. vol 98. issue 2. 2011-07-08. PMID:21236292. |
these behavioral changes were accompanied by a decrease in the dopamine and its metabolite, dopac concentration in the frontal cortex, enhanced dopaminergic system activity in the striatum and no changes in noradrenaline (na) level. |
2011-07-08 |
2023-08-12 |
rat |
| Anjali Rao, Diana Simmons, Alexander Sorki. Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons. Molecular and cellular neurosciences. vol 46. issue 1. 2011-07-05. PMID:20816972. |
differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons. |
2011-07-05 |
2023-08-12 |
rat |
| Anjali Rao, Diana Simmons, Alexander Sorki. Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons. Molecular and cellular neurosciences. vol 46. issue 1. 2011-07-05. PMID:20816972. |
dopamine (da) transporter (dat) functions at the surface of dopaminergic neurons to clear extracellular da. |
2011-07-05 |
2023-08-12 |
rat |
| James P Dugan, Andrea Stratton, Hilary P Riley, W Todd Farmer, Grant S Mastic. Midbrain dopaminergic axons are guided longitudinally through the diencephalon by Slit/Robo signals. Molecular and cellular neurosciences. vol 46. issue 1. 2011-07-05. PMID:21118670. |
dopaminergic neurons from the ventral mesencephalon/diencephalon (mesodiencephalon) form vital pathways constituting the majority of the brain's dopamine systems. |
2011-07-05 |
2023-08-12 |
mouse |
| Jean Lud Cadet, Christie Brannock, Irina N Krasnova, Bruce Ladenheim, Michael T McCoy, Jenny Chou, Elin Lehrmann, William H Wood, Kevin G Becker, Yun Wan. Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats. PloS one. vol 5. issue 12. 2011-07-05. PMID:21179447. |
the present experiments sought to identify genes that were affected in the dopamine (da)-denervated striatum after 6-hydroxydopamine-induced destruction of the nigrostriatal dopaminergic pathway in the rat. |
2011-07-05 |
2023-08-12 |
rat |
| Kenji Ishibashi, Kenji Ishii, Keiichi Oda, Hidehiro Mizusawa, Kiichi Ishiwat. Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457. PloS one. vol 6. issue 3. 2011-07-05. PMID:21408026. |
the purpose of this study was to determine the binding sites of pramipexole in extrastriatal dopaminergic regions because its antidepressive effects have been speculated to occur by activating the dopamine d(2) receptor subfamily in extrastriatal areas. |
2011-07-05 |
2023-08-12 |
human |
| Brendon W Kent, Zachary A Weinstein, Vincent Passarelli, Yue Chen, Larry J Sieve. Deficient visual sensitivity in schizotypal personality disorder. Schizophrenia research. vol 127. issue 1-3. 2011-07-01. PMID:20541911. |
since dopamine in the retina enhances visual contrast detection and spd patients have relatively reduced dopaminergic activity in the brain compared to schizophrenia patients, it was hypothesized that spd patients would have decreased to normal contrast sensitivity. |
2011-07-01 |
2023-08-12 |
human |
| Jussi Hirvonen, Jarmo Hietal. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems. CNS neuroscience & therapeutics. vol 17. issue 2. 2011-07-01. PMID:21199447. |
dopaminergic alterations in schizophrenia are shared by individuals at genetic risk who do not express the illness, suggesting a "dopamine hypothesis of schizophrenia vulnerability." |
2011-07-01 |
2023-08-12 |
Not clear |
| Sehyoun Yoon, Mi-hyun Choi, Min Seok Chang, Ja-Hyun Bai. Wnt5a-dopamine D2 receptor interactions regulate dopamine neuron development via extracellular signal-regulated kinase (ERK) activation. The Journal of biological chemistry. vol 286. issue 18. 2011-07-01. PMID:21454669. |
the dopamine d2 receptor (d2r) plays an important role in mesencephalic dopaminergic neuronal development, particularly coupled with extracellular signal-regulated kinase (erk) activation. |
2011-07-01 |
2023-08-12 |
mouse |
| G Conductier, J-L Nahon, A Guyo. Dopamine depresses melanin concentrating hormone neuronal activity through multiple effects on α2-noradrenergic, D1 and D2-like dopaminergic receptors. Neuroscience. vol 178. 2011-06-27. PMID:21262322. |
dopamine depresses melanin concentrating hormone neuronal activity through multiple effects on α2-noradrenergic, d1 and d2-like dopaminergic receptors. |
2011-06-27 |
2023-08-12 |
mouse |
| Andrew J Levine, Elyse J Singer, Paul Shapsha. The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders. AIDS and behavior. vol 13. issue 1. 2011-06-21. PMID:18264751. |
we focus on the role of dopamine dysfunction in the etiology of hand, and propose a number of genetic polymorphisms within genes related to dopaminergic functioning and other neurobiological factors that may confer vulnerability or protection against hand. |
2011-06-21 |
2023-08-12 |
human |
| Hannah F Clarke, Gemma J Hill, Trevor W Robbins, Angela C Robert. Dopamine, but not serotonin, regulates reversal learning in the marmoset caudate nucleus. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 31. issue 11. 2011-06-15. PMID:21411670. |
therefore, because the roles of the serotonin and dopamine within the caudate nucleus are poorly understood, this study compared the effects of selective serotoninergic or selective dopaminergic depletions of the marmoset medial caudate nucleus on serial discrimination reversal learning. |
2011-06-15 |
2023-08-12 |
monkey |
| Hans C Lou, Joshua C Skewes, Kristine Rømer Thomsen, Morten Overgaard, Hakwan C Lau, Kim Mouridsen, Andreas Roepstorf. Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words. Journal of vision. vol 11. issue 2. 2011-06-07. PMID:21346001. |
in a controlled study of 24 normal, healthy female university students with the dopamine agonist pergolide given orally, we show that dopaminergic activation increases confidence in seeing rapidly presented words. |
2011-06-07 |
2023-08-12 |
human |
| Keith M Gunapala, Daniel Chang, Cynthia T Hsu, Kebreten Manaye, Ryan M Drenan, Robert C Switzer, Andrew D Steel. Striatal pathology underlies prion infection-mediated hyperactivity in mice. Prion. vol 4. issue 4. 2011-06-06. PMID:20948312. |
an assessment of neuromodulatory systems including serotonin, dopamine, noradrenalin and acetylcholine showed surprisingly little decline in neuronal cell bodies or their innervations of regions controlling locomotor behavior, except for a small decrease in dopaminergic innervations of the dorsal striatum. |
2011-06-06 |
2023-08-12 |
mouse |
| Nuska Tschammer, Jan Elsner, Angela Goetz, Katharina Ehrlich, Stefan Schuster, Miriam Ruberg, Julia Kühhorn, Dawn Thompson, Jennifer Whistler, Harald Hübner, Peter Gmeine. Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor-ligand interactions. Journal of medicinal chemistry. vol 54. issue 7. 2011-06-06. PMID:21388142. |
heterocyclic dopamine surrogates of types 5 and 7 were synthesized and investigated for their dopaminergic properties. |
2011-06-06 |
2023-08-12 |
Not clear |
| Zvezdan Pirtoše. Myths and realities of continuous dopaminergic stimulation. Psychiatria Danubina. vol 23. issue 1. 2011-06-02. PMID:21448103. |
continuous dopaminergic stimulation has been shown to dramatically improve motor fluctuations and dyskinesia by modifications of oral treatment (dopamine agonists, smaller, more frequent levodopa doses, controlled-release formulation of levodopa, addition of agents that slow down the catabolism of dopamine, such as inhibitors of catechol-o-methyl transferase and monoamine oxidase), transdermal delivery (rotigotine), infusion therapies (intravenous levodopa, subcutaneous application of apomorphine and lisuride, duodenal infusion of levodopa) and deep brain stimulation of the subthalamic nucleus. |
2011-06-02 |
2023-08-12 |
Not clear |
| Esther M Opmeer, Rudie Kortekaas, André Alema. Depression and the role of genes involved in dopamine metabolism and signalling. Progress in neurobiology. vol 92. issue 2. 2011-06-01. PMID:20558238. |
according to the dopamine theory of affective disorders, a deficiency in dopaminergic neurotransmission may play a role in the major symptoms of mdd. |
2011-06-01 |
2023-08-12 |
Not clear |
| Maria Rosaria Melis, Antonio Argiola. Central control of penile erection: a re-visitation of the role of oxytocin and its interaction with dopamine and glutamic acid in male rats. Neuroscience and biobehavioral reviews. vol 35. issue 3. 2011-06-01. PMID:21050872. |
dopamine released in the nucleus accumbens in turn activates neural pathways leading to the activation of incerto-hypothalamic dopaminergic neurons in the paraventricular nucleus. |
2011-06-01 |
2023-08-12 |
rat |
| Sung W Choi, Akos A Gerencser, Donna W Lee, Subramanian Rajagopalan, David G Nicholls, Julie K Andersen, Martin D Bran. Intrinsic bioenergetic properties and stress sensitivity of dopaminergic synaptosomes. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 31. issue 12. 2011-05-27. PMID:21430153. |
to circumvent damage induced by synaptosomal separation, we monitored membrane potentials in whole unseparated single synaptosomes using fluorescent imaging, and then identified the dopaminergic subpopulation using a fluorescent dopamine transporter substrate (asp(+) [4-(4-diethylaminostyryl)-n-methylpyridinium iodide]). |
2011-05-27 |
2023-08-12 |
mouse |
| Esther Fujimoto, Tamara J Stevenson, Chi-Bin Chien, Joshua L Bonkowsk. Identification of a dopaminergic enhancer indicates complexity in vertebrate dopamine neuron phenotype specification. Developmental biology. vol 352. issue 2. 2011-05-26. PMID:21276790. |
identification of a dopaminergic enhancer indicates complexity in vertebrate dopamine neuron phenotype specification. |
2011-05-26 |
2023-08-12 |
mouse |